9.13.23
7.21.22
6.29.22
12.29.21
8.03.21
4.18.21
8.05.20
5.20.20
3.12.20
7.15.19
6.25.19
Recently, the U.S. Food and Drug Administration, or the FDA, announced enhancement of the FDA's Paragraph IV Patent Certification List (the List) as part of the agency's stated goal of bringing more generic drugs to market faster in the United States.